The S100 protein family comprises low-molecular-weight calcium-binding proteins characterized by two EF-hand calcium-binding motifs. In diagnostic neuropathology, the term S100 protein generally refers to antibodies recognizing S100A1 and S100B subunits, which form homo- and heterodimers predominantly expressed in glial cells, Schwann cells, melanocytes, and other neural crest-derived cell populations. S100 proteins regulate calcium homeostasis, cytoskeletal dynamics, cellular differentiation, proliferation, migration, and survival through intracellular signaling and extracellular receptor-mediated pathways. Within the central and peripheral nervous systems, S100 proteins are highly expressed in astrocytes, Schwann cells, satellite glial cells, ependymal cells, sustentacular cells, and other glial populations.

Biological Significance of S100 Protein

• Highly expressed in astrocytes, Schwann cells, satellite glial cells, and other glial populations.
• Functions as a regulator of intracellular calcium signaling, cytoskeletal organization, and cellular homeostasis.
• Participates in neuronal development, myelination, neuroinflammation, tissue repair, and cellular stress responses.
• Extracellular S100 proteins may act as cytokine-like mediators through activation of receptors such as RAGE and Toll-like receptors (TLRs).

Diagnostic Utility of S100 Protein in Neuropathology

Sensitive marker of Schwann cell lineage differentiation in:

• Schwannoma.
• Neurofibroma.
• Granular cell tumor.

Supports the diagnosis of malignant peripheral nerve sheath tumor (MPNST), although staining may be focal, heterogeneous, or reduced in high-grade lesions.

Useful as a sensitive but relatively non-specific marker of astrocytic and Schwannian differentiation, particularly when interpreted alongside lineage-specific markers such as GFAP, OLIG2, and SOX10.

Commonly incorporated into antibody panels for the evaluation of melanocytic tumors, clear cell sarcoma, and selected dendritic or histiocytic proliferations involving the nervous system.

Key Features of CE/IVD Anti-S100 Antibodies

• Validated for formalin-fixed paraffin-embedded (FFPE) tissue sections.
• Optimized for automated and manual immunohistochemistry platforms.
• Typically demonstrate nuclear and cytoplasmic immunoreactivity in positive cells according to the manufacturer's validated protocol.
• High analytical sensitivity for detecting glial and Schwann cell populations.
• Manufactured in compliance with CE/IVD regulatory requirements to support routine clinical diagnostics and standardized laboratory workflows.